Marinomed Biotech AG (MARI VI) stock market data APIs
€19.0717
-0.07(-0.4%)
as of December 30, 2025
Try our APIs with
free plan!
Marinomed Biotech AG Financial Data Overview
Price chart is built with
Anychart
Marinomed Biotech AG, a biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally. It operates through Virology, Immunology, and Other segments. The company's products pipeline includes Budesolv for the treatment of allergic rhinitis; Tacrosolv, which is in Phase II clinical trial for inflammatory eye diseases; and Inhaleen for viral infection of the upper and lower respiratory tract. It also provides Solv4U which offers formulation development and biopharmaceutical testing services. It has a technology partnership with SPH Sine Pharmaceutical Laboratories Co. Ltd. The company was formerly known as Marinomed Biotechnologie GmbH and changed its name to Marinomed Biotech AG in June 2017. Marinomed Biotech AG was incorporated in 2006 and is headquartered in Korneuburg, Austria.
Prev. Close
19.0717
Open
19.0035
High
19.2389
Low
18.4189
52 wk Range
11.7-21
Market Cap
35 143 K
P/E Ratio
3.4982
Shares Outstanding
1 840 K
Revenue
9 761 K
EPS
-0.4043
Beta
-0.261
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Marinomed Biotech AG data using free add-ons & libraries
Get Marinomed Biotech AG Fundamental Data
Marinomed Biotech AG Fundamental data includes:
- Net Revenue: 9 761 K
- EBITDA: -1 570 542
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-04-19
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Marinomed Biotech AG News
New
European Growth Companies Insiders Are Betting On
Amidst concerns over the independence of the U.S. Federal Reserve and renewed tariff uncertainties, European markets have been experiencing a downturn, with major indices such as the STOXX Europe 600 ...
Top European Growth Companies With Strong Insider Ownership
As European markets experience a lift from easing trade tensions and optimism over potential U.S. interest rate cuts, the pan-European STOXX Europe 600 Index has seen notable gains. In this environmen...
European Growth Companies With High Insider Ownership
As European markets experience a positive upswing, with the STOXX Europe 600 Index climbing on strong corporate earnings and optimism surrounding geopolitical tensions, investors are increasingly look...
3 European Growth Stocks With High Insider Ownership And Up To 60% Earnings Growth
Amid a backdrop of trade tensions and economic uncertainty, European markets have experienced declines, with major indices such as the STOXX Europe 600 Index ending lower. Despite these challenges, gr...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
